Deficiency of C3a receptor attenuates the development of diabetic nephropathy
Objective Diabetic nephropathy (DN) is the leading cause of chronic kidney disease and end-stage renal disease. Emerging evidence suggests that complement activation is involved in the pathogenesis of DN. The aim of this study was to investigate the pathogenic role of C3a and C3a receptor (C3aR) in...
Saved in:
| Main Authors: | Ming-hui Zhao, Xiao-Qian Li, Dong-Yuan Chang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/7/1/e000817.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of complement C3 in diabetic nephropathy
by: Wang Qing-qing, et al.
Published: (2022-07-01) -
Role of Bile Acid Receptors in the Development and Function of Diabetic Nephropathy
by: Yuanyuan Fang, et al.
Published: (2024-11-01) -
Mechanisms of active components of Astragalus membranaceus in regulating the NLRP3 inflammasome to attenuate diabetic nephropathy
by: Qiao Lin, et al.
Published: (2025-05-01) -
Attenuation of Diabetic Nephropathy in Diabetic Mice by Fasudil through Regulation of Macrophage Polarization
by: Fajiang Xie, et al.
Published: (2020-01-01) -
Predictive value of serum IgG/C3 levels for membranous nephropathy in diabetics with proteinuria and negative phospholipase A2 receptor antibody
by: Huan Wang, et al.
Published: (2024-12-01)